The role of association of ADRB2 gene polymorphism with therapeutic response to β2-agonists in  children with recurrent bronchial obstruction

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2370

Full metadata record

DC Field	Value	Language
dc.contributor.author	Karimdzhanov I.A., Zakirova U.I., Yusupova G.A., Karimova U.N	-
dc.date.accessioned	2022-10-03T10:37:25Z	-
dc.date.available	2022-10-03T10:37:25Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2370	-
dc.description.abstract	The study of the effect of drugs at the molecular genetic level in the recurrent course of bronchialobstruction (RBО) in children improved the understanding of the pathogenesis of the disease and made it possible tobetter characterize the reliability of use in therapy. The aim of the study was to assess the clinical significance of the polymorphism of the Arg16Gly loci of the ADRB2 gene with a therapeutic response to β2-agonists in children with RBО of Uzbek ethnicity.	en_US
dc.language.iso	en	en_US
dc.publisher	Украина	en_US
dc.relation.ispartofseries	UDC;616.233-002:616-036:616-053	-
dc.subject	Вronchitis; obstruction; ADRB2 gene; β2-agonists; children	en_US
dc.title	The role of association of ADRB2 gene polymorphism with therapeutic response to β2-agonists in children with recurrent bronchial obstruction	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
2.1 scopus.pdf	The role of association of ADRB2 gene polymorphism with therapeutic response to β2-agonists in children with recurrent bronchial obstruction	1.27 MB	Adobe PDF	View/Open

DSpace JSPUI